Replies to post #15416 on NorthWest Biotherapeutics Inc (NWBO)

[longtermthinker]

1000% agree with maverick 1's post
Even the citation from SOS. Problem is, NWBO has bigger problems than just manipulators. It has a CEO who continues to present herself as if she were running one of those pump and dump marijuana products companies. Her PR rings hollow and false and her responses to critics are idiotic and rarely, if ever, to the point. Be honest, don't you think as an investor you should have better understanding of events, such as Phase III delays, expansion of trials, Germany compassionate usage progress, etc. And, by the way, nobody has YET come across with a convincing argument as to why NWBO's therapies are that much better than those of IMUC. Results in phase II looked to be only marginally better. So, I think, if this company sees a rejection in phase III, they are obviously done for; but, if they get an approval, they may just die a slower death like DNDN which can't find enough folks to buy their product. Then last of all, the whole silliness with the phase I trials should give any intelligent investor serious pause before throwing money at this thing. The phase I debacle is a disgrace. That is one that the SEC needs to look into, forget the ambulance chasing lawyer maggots!